(lp0
S'Cyclacel Pharmaceuticals: Is There Anything Left In The Tank? Seeking Alpha - Mar 9, 2017 Cyclacel Pharmaceuticals Inc.,  is a small biopharmaceutical company that works on developing oral therapies for the treatment of various cancers and diseases with high unmet medical need.Analyst Hints Surrounding Cyclacel Pharmaceuticals, Inc.  - Post Analyst'
p1
aS"Monday's Market Insights: Cyclacel Pharmaceuticals Inc , DryShips Inc ... Smarter Analyst - Apr 3, 2017 Cyclacel Pharmaceuticals Inc  is the big winner today - largely thanks to optimism surrounding the company's cancer drug candidate, CYC065.Cyclacel Pharmaceuticals Inc.  Is Spiking Higher On CYC065 News - RTT NewsCyclacel Pharmaceuticals Inc  Shares Rise on Pre-Clinical Data ... - Small Cap Exclusive "
p2
aS"Cyclacel Pharmaceuticals Inc  Is Today's Biotech Focus Insider Financial - Apr 10, 2017 The share price of Cyclacel Pharmaceuticals , the biopharmaceutical company developing small molecule drugs for the treatment of cancer, jumped around 140% in just two days from $4.33 per share, as positive results were released about&nbsp;...Cyclacel Pharmaceuticals, Inc.  Recent Ownership Changes - Post Analyst"
p3
aS"Cyclacel Pharmaceuticals, Inc.'s  CEO Spiro Rombotis on Q2 2016 Results ... Seeking Alpha - Aug 10, 2016 Good afternoon and welcome to the Cyclacel Pharmaceutical's Second Quarter 2016 Results Conference Call and Webcast. Today's call is being recorded."
p4
aS'This Is What The Technical Chart For Cyclacel Pharmaceuticals, Inc.  Is ... NY Stock News - Apr 5, 2017 Cyclacel Pharmaceuticals, Inc.  is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how investors and traders should be approaching CYCC.'
p5
aS'Cyclacel Pharmaceuticals, Inc.  And Its Technical Chart Creates A ... NY Stock News - Apr 4, 2017 Cyclacel Pharmaceuticals, Inc.  has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.'
p6
aS"Cyclacel's Date With Decitabine Seeking Alpha - Aug 22, 2016 Cyclacel's  long-suffering shareholders will shortly see the outcome of its seemingly endless, so-called Seamless trial of sapacitabine in elderly patients with newly diagnosed acute myeloid leukaemia, after the study finally reached the&nbsp;..."
p7
aS'Novocure and Cyclacel Pharmaceuticals Surge on Positive FDA Trial News Yahoo Finance - Apr 4, 2017 Cyclacel Pharmaceuticals advanced 74.46% to close at $6.42 on Monday. The stock traded between $4.12 and $6.59 on volume of 12.9 million shares traded.'
p8
aS"Cyclacel Pharmaceuticals Inc : Don't Believe the Hype Investorplace.com - Aug 22, 2016 Cyclacel Pharmaceuticals Inc  hasn't exactly had a bad year - CYCC stock was up 15.5% for the year through Friday.Cyclacel Pharmaceuticals Inc  Spikes On Tang Capital Stake - Schaeffers Research Here's Why Cyclacel Pharmaceuticals  Stock Is Surging Today - TheStreet.com"
p9
aS'Hot Stocks Report: Cyclacel Pharmaceuticals, Inc. , Karyopharm ... Post Analyst - Apr 17, 2017 Cyclacel Pharmaceuticals, Inc. has a consensus outperform rating from 1 Wall Street analysts, and the number of shares currently sold short amount to at least 10.63% of shares outstanding.'
p10
a.